Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


01 febrero 2014

JOURNAL OF ENDOVASCULAR THERAPY. Paclitaxel-Eluting Balloon vs. Standard Angioplasty to Reduce Recurrent Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: The DEBATE-ISR Study

Francesco Liistro, MD1⇑ Paolo Angioli, MD1 Italo Porto, MD, PhD1 Lucia Ricci, MD2 Kenneth Ducci, MD1 Simone Grotti, MD1,3 Giovanni Falsini, MD1 Giorgio Ventoruzzo, MD1 Filippo Turini, MD1 Guido Bellandi, MD1 Leonardo Bolognese, MD1

Purpose: To test the ability of a drug-eluting balloon (DEB) to reduce recurrent in-stent restenosis (ISR) in diabetic patients with femoropopliteal stents.

01 febrero 2014

JOURNAL OF ENDOVASCULAR THERAPY. Nitinol Self-Expanding Stents vs. Balloon Angioplasty for Very Long Femoropopliteal Lesions

Ehrin J. Armstrong, MD, MSc1 Haseeb Saeed, MD2 Bejan Alvandi, BS2 Satinder Singh, MD2 Gagan D. Singh, MD2 Khung Keong Yeo, MBBS2 David Anderson, BA2 Gregory G. Westin, BA2 David L. Dawson, MD3 William C. Pevec, MD3 John R. Laird, MD2⇑

Purpose: To compare the patency rates and clinical outcomes of balloon angioplasty vs. nitinol stent placement for patients with short (≤150 mm) as compared to long (>150 mm) femoropopliteal (FP) occlusive lesions.

01 febrero 2014

JOURNAL OF ENDOVASCULAR THERAPY. Photoablation Using the Turbo-Booster and Excimer Laser for In-Stent Restenosis Treatment: Twelve-Month Results From the PATENT Study

Andrej Schmidt, MD1⇑ Thomas Zeller, MD2 Horst Sievert, MD3 Hans Krankenberg, MD4 Giovanni Torsello, MD5 Matthew A. Stark, PhD6 Dierk Scheinert, MD1

Purpose: To evaluate the performance of the Turbo Elite laser catheter in combination with the Turbo-Booster guiding catheter for the treatment of femoropopliteal in-stent restenosis (ISR).

01 febrero 2014

JOURNAL OF ENDOVASCULAR THERAPY. Revascularization of Lower Extremity Chronic Total Occlusions With a Novel Intraluminal Recanalization Device: Results of the ReOpen Study

Marc Bosiers, MD1⇑ Juan Diaz-Cartelle, MD2 Dierk Scheinert, MD3 Patrick Peeters, MD4 Keith D. Dawkins, MD2

Purpose To report outcomes of a multicenter, nonrandomized study evaluating the safety and effectiveness of a guidewire-mounted mechanical recanalization device with a rotating distal tip (TruePath) in facilitating the crossing of infrainguinal chronic total occlusions (CTOs).

01 febrero 2014

JOURNAL OF ENDOVASCULAR THERAPY. One-Year Outcomes Following Repair of Thoracoabdominal Aneurysms With the Multilayer Flow Modulator: Report From the STRATO Trial

Claude D. Vaislic, MD1⇑ Jean Noël Fabiani, MD, PhD2 Sidney Chocron, MD, PhD3 Jacques Robin, MD4 Victor S. Costache, MD5 Jean-Pierre Villemot, MD, PhD6 Jean Marc Alsac, MD2 Pascal N. Leprince, MD, PhD7 Thierry Unterseeh, MD8 Eric Portocarrero, MD6 Yves Glock, MD, PhD9 Hervé Rousseau, MD, PhD on behalf of the STRATO Investigators Group

Purpose: To evaluate endovascular repair of type II and III thoracoabdominal aortic aneurysms (TAAA) using the Multilayer Flow Modulator (MFM) in patients with contraindications for open surgery and fenestrated stent-grafts.

01 febrero 2014

JOURNAL OF ENDOVASCULAR THERAPY. When Not to Implant the Multilayer Flow Modulator: Lessons Learned From Application Outside the Indications for Use in Patients With Thoracoabdominal Pathologies

Sherif Sultan, MCh, MD, FRCS, EBQS/Vasc1,2 Niamh Hynes, MD, MRCS2 Mohamed Sultan on behalf of the MFM Collaborators

Purpose: To scrutinize registry data on thoracoabdominal repairs performed using the Multilayer Flow Modulator (MFM) outside the indications for use (IFU) and analyze the adverse outcomes.

01 marzo 2014

RADIOLOGY. Inferior Mesenteric Arterial Type II Endoleaks after Endovascular Repair of Abdominal Aortic Aneurysm: Are They Predictable?

Oliver Güntner, MD, Florian Zeman, MMath, Walter A. Wohlgemuth, MD, Peter Heiss, MD, Ernst Michael Jung, MD, Philipp Wiggermann, MD, Karin Pfister, MD, Christian Stroszczynski, MD, René Müller-Wille, MD

Endovascular aortic aneurysm repair (EVAR) is widely accepted as a less-invasive alternative to traditional open surgery in patients with an infrarenal abdominal aortic aneurysm. However, type II endoleaks continue to be the most common complications observed after EVAR, occurring in 19%–23% of patients (1,2). Type-II endoleaks are caused by retrograde collateral blood flow into the aneurysm sac from patent aortic side branches such as the inferior mesenteric artery (IMA), lumbar arteries, or median sacral artery (3). Type II endoleaks can be classified as simple or complex. Simple endoleaks have only one artery in communication with the aneurysm sac, whereas complex endoleaks have multiple communicating arteries (3). Persistent flow in the IMA is responsible for 45%–85% of all type II endoleaks after EVAR (4,5). Baum and colleagues (6) demonstrated that retrograde blood flow in the IMA transmits nearly systemic pressures to the aneurysm sac. Persistent pressurization of the aneurysm sac is significantly associated with aneurysm sac growth, repeated secondary intervention, conversion to open repair, and even aneurysm rupture (2,7,8).

01 febrero 2014

RADIOLOGY. Cellular Mechanisms of Aneurysm Occlusion after Treatment with a Flow Diverter

Ramanathan Kadirvel, PhD, Yong-Hong Ding, MD, Daying Dai, MD, Issa Rezek, MD, Debra A. Lewis, PhD, David F. Kallmes, MD

Flow diverters provide a noninvasive way of treating aneurysms that are otherwise difficult to treat with other endovascular techniques. Even though flow diverters are widely applied, their exact mechanism of action remains unknown. Notwithstanding the term flow diverter, which implies that the primary mode of action is diversion of flow from the aneurysm (1–4), it remains unclear whether change in intraaneurysmal flow, tissue growth across the neck, or both processes are dominant predictors of long-term occlusion. Ongoing uncertainty regarding the exact healing mechanism associated with flow diverters has myriad consequences, including but not limited to impeding our ability to develop next-generation devices. The objective of our study was to characterize the progression of healing across aneurysm necks following treatment with a flow diverter in a rabbit model.

03 diciembre 2013

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Peripheral Artery Disease. Preoperative Statins and Limb Salvage After Lower Extremity Revascularization in the Medicare Population

Todd R. Vogel, MD, MPH, Viktor Y. Dombrovskiy, MD, PhD, MPH, Edgar Luis Galiñanes, MD and Robin L. Kruse, PhD

Background: Statins stabilize atherosclerotic plaque, decrease mortality after surgical procedures, and are linked to anti-inflammatory effects. The objective of this study was to evaluate preoperative administration of statins and longitudinal limb salvage after lower extremity endovascular revascularization and lower extremity open surgery.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.